PharmaCorp Rx Inc. (TSXV:PCRX)

PharmaCorp Rx Revenue

PharmaCorp Rx had revenue of 7.19M CAD in the quarter ending March 31, 2026, with 79.40% growth. This brings the company's revenue in the last twelve months to 24.08M, up 145.63% year-over-year. In the year 2025, PharmaCorp Rx had annual revenue of 20.89M with 260.57% growth.

• Revenue (ttm): 24.08M
• Revenue Growth: +145.63%
• P/S Ratio: 3.69
• Revenue / Employee: 4.82M
• Employees: 5
• Market Cap: 88.78M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.89M	15.10M	260.57%
Dec 31, 2024	5.79M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error